| Announce Date | 11/12/2025 |
| EPS Normalized Actual | $0.5 (Beat by $0.16) |
| EPS GAAP Actual | $0.5 (Beat by $0.16) |
| Revenue Actual | $0.7944B |
| Revenue Surprise | Beat by $794.4M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.21966 |
| EPS GAAP Estimate | $0.21966 |
| Revenue Estimate | $0.901554452B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 2.98016 | 14.88 | 2.87588 | 3.10435 | 1 |
| Dec 2028 | 2.17972 | 20.34 | 2.11838 | 2.25612 | 3 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.36 | 0.36 | 0.7944B | 19.96% | 794.4M |
| FQ2 2025 (Jun 2025) | -0.12 | -0.12 | 0.7492B | 24.68% | 749.2M |
| FQ1 2025 (Mar 2025) | 0.14 | 0.14 | 0.7266B | 27.84% | 726.6M |
| FQ4 2024 (Dec 2024) | 0.26 | 0.26 | 0.6066B | 30.06% | 606.6M |
| FQ3 2024 (Sep 2024) | 0 | 0 | 0.6358B | 24.43% | 635.8M |
| FQ2 2024 (Jun 2024) | 0.0949 | 0.0949 | 0.564279B | 21.26% | 564.28M |
| FQ1 2020 (Mar 2020) | -0.0638 | -0.0638 | 0.085459B | 100% | 85.46M |
| FQ2 2020 (Jun 2020) | -0.0638 | -0.0638 | 0.085459B | 100% | 85.46M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.21966
Consensus Revenue Estimates
0.901554452B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.33724 | -- | 0.32237 | 0.35317 | 2 |
| FQ3 2027 (Sep 2027) | 0.58875 | -- | 0.56278 | 0.61656 | 2 |
| FQ2 2027 (Jun 2027) | 0.47144 | -- | 0.45065 | 0.49371 | 2 |
| FQ1 2027 (Mar 2027) | 0.40631 | -- | 0.38839 | 0.4255 | 2 |
| FQ4 2026 (Dec 2026) | 0.3137 | -- | 0.29987 | 0.32852 | 2 |
| FQ3 2026 (Sep 2026) | 0.47617 | 24.4 | 0.45517 | 0.49866 | 3 |
| FQ2 2026 (Jun 2026) | 0.37427 | 132.06 | 0.35776 | 0.39195 | 4 |
| FQ1 2026 (Mar 2026) | 0.21966 | 36.27 | 0.21554 | 0.23172 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.36B | -- | 1.31B | 1.41B | 8 |
| FQ3 2027 (Sep 2027) | 1.52B | -- | 1.47B | 1.57B | 5 |
| FQ2 2027 (Jun 2027) | 1.4B | -- | 1.35B | 1.45B | 4 |
| FQ1 2027 (Mar 2027) | 1.32B | -- | 1.28B | 1.37B | 8 |
| FQ4 2026 (Dec 2026) | 1.13B | -- | 1.09B | 1.17B | 7 |
| FQ3 2026 (Sep 2026) | 1.24B | 35.83 | 1.2B | 1.28B | 4 |
| FQ2 2026 (Jun 2026) | 1.14B | 34.46 | 1.1B | 1.18B | 4 |
| FQ1 2026 (Mar 2026) | 0.9B | 19.41 | 0.89B | 0.94B | 9 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.36 | 0.36 | 100% | |
| FQ2 2025 (Jun 2025) | -0.12 | -0.12 | 100% | |
| FQ1 2025 (Mar 2025) | 0.14 | 0.14 | 100% | |
| FQ4 2024 (Dec 2024) | 0.26 | 0.26 | 100% | |
| FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | 0.0949 | 0.0949 | 100% | |
| FQ1 2020 (Mar 2020) | -0.0638 | -0.0638 | 100% | |
| FQ2 2020 (Jun 2020) | -0.0638 | -0.0638 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.79B | $794.4M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.75B | $749.2M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.73B | $726.6M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.61B | $606.6M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.64B | $635.8M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.56B | $564.28M | 100% |
| FQ1 2020 (Mar 2020) | $0B | $0.09B | $85.46M | 100% |
| FQ2 2020 (Jun 2020) | $0B | $0.09B | $85.46M | 100% |